Obesity may raise risk of ovarian cancer

	Tweet

Obese women may have a higher risk of developing ovarian cancer than their thinner counterparts, a large study of U.S. women suggests.

Ovarian cancer is a particularly deadly type of cancer because in the initial stages it typically has vague symptoms or none at all, making it difficult to catch early.

In the new study, which included more than 94,000 U.S. women ages 50 to 71, who were followed for more than 7 years, the researchers found that obese women were more likely to develop ovarian cancer. But the risk appeared to be confined to those who’d never used hormone replacement therapy (HRT) during menopause. Previous studies have linked hormone use to a reduced risk of ovarian cancer.

Among women who’d never used HRT, those who were obese had an 83 percent higher risk of ovarian cancer that normal-weight women did.

The findings, reported in the journal Cancer, suggest that obesity may be one of a few controllable risk factors for ovarian cancer.

They also offer women one more potential reason to avoid unhealthy weight gain, said lead researcher Dr. Michael F. Leitzmann, of the U.S. National Cancer Institute in Bethesda, Maryland and the University of Regensburg in Germany.

“Our data suggest that maintaining a healthy weight is associated with a reduction in the risk of developing ovarian cancer,” Leitzmann told Reuters Health.

It’s not entirely clear why obesity may contribute to ovarian cancer, but it may have to do with the effects of excess body fat on a woman’s estrogen levels, according to Leitzmann and his colleagues. The fact that the risk varied according to women’s HRT use supports this theory, the researchers note.

The study also found a link between obesity at the age of 18 and a higher risk of ovarian cancer later in life—a relationship was even stronger than the one between later-life obesity and ovarian cancer risk.

It’s possible, the researchers say, that weight in adolescence or young adulthood is even more relevant to ovarian cancer than weight gain later in life.

SOURCE: Cancer, February 15, 2009.

RELATED STORIES:
Possible New Therapy for Patients with Platinum-Resistant Ovarian Cancer   Blood test detects ovarian cancer early   Early periods may reduce ovarian cancer survival   Survivors of Rare Ovarian Cancer Retain Fertility, Have Positive Relationships   BRCA2 genetic mutation associated with improved survival and chemotherapy response in ovarian cancer   Study Reveals Why Certain Ovarian Cancers Develop Resistance to Platinum-based Chemotherapy   Extracellular protein sensitizes ovarian cancer cells to chemotherapy   Low-fat diet possibly linked to lower risk of ovarian cancer   Cancer stem cells recruit normal stem cells to fuel ovarian cancer, U-M study finds   Ovarian cancer patients survive longer with BRCA2 mutated in tumors   Low-dose Pill reduces ovarian cancer risk   Team effort to beat ovarian cancer   Physical activity does not ward off ovarian cancer   Ovarian cancer screening popular despite guidelines   4 possible risk factors for ovarian cancer found   Two gene mutations mark deadly ovarian cancer   Soy may lessen risk of endometrial, ovarian cancers   Ovarian cancer subtypes are different diseases: Implications for biomarker studies   Excess weight worsens ovarian cancer prognosis   Higher BMI Tied to Ovarian Cancer Risk   Roche upbeat on Avastin in ovarian cancer   Ovarian Cancer May Mimic Fallopian Tube Formation

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]